Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001402543 | SCV001604394 | likely benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2024-06-13 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004531226 | SCV004721764 | uncertain significance | RTEL1-related disorder | 2024-01-29 | no assertion criteria provided | clinical testing | The RTEL1 c.3415+8G>C variant is predicted to interfere with splicing. This variant is not predicted to change the strength of the canonical splice site but may result in the production of a new cryptic splice donor site according to an in silico splicing algorithm (SpliceAI, Jaganathan K, et al. 2019. PubMed ID: 30661751). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0037% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |